Atypical hemolytic uremic syndrome (aHUS) is a potentially life-threatening condition that causes small blood clots and organ damage. It’s often caused by a genetic mutation that affects your immune system. People with aHUS have episodes of anemia, low platelets and kidney failure. Pregnancy, infections and medications can trigger these episodes.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Atypical hemolytic uremic syndrome (aHUS) is a condition that causes parts of your immune system to mistakenly attack the cells lining your blood vessels. This leads to small blood clots, reducing blood flow to your kidneys and other organs. AHUS is often caused by a genetic mutation.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Healthcare providers usually diagnose aHUS when you have three conditions together:
These three conditions can happen in episodes that are triggered by other health conditions.
In the past, HUS was categorized into two types:
Having a genetic mutation alone doesn’t usually cause atypical hemolytic uremic syndrome. More often, it’s triggered by other health conditions, including:
Certain medications, including some cancer chemotherapy agents, immunosuppressive medications, blood thinners, oral contraceptives (birth control pills) and anti-inflammatory medications.
Advertisement
Symptoms of aHUS include:
Most people only experience a few symptoms of aHUS, or symptoms come on slowly. You might feel like you’ve been sick for a while with something you just can’t shake. Neurological (brain and nerve) symptoms, like confusion, are less common.
A genetic mutation (a change in your DNA) or autoantibodies (proteins that attack your body’s cells) you develop against complement proteins cause atypical hemolytic uremic syndrome. You can inherit these changes from a biological parent or they can happen on their own (sporadic). Gene mutations can affect proteins called complement factors.
Complement factors are proteins that help immune cells identify and destroy harmful pathogens (germs, like bacteria and viruses). Similar to seasoning on your food, complement proteins coat pathogens and make them “tasty” so that other immune cells will ingest them. Genetic mutations in aHUS most commonly affect complement factors H, I, 3 and B.
For example, complement factor H protects your body’s cells so other complement factors won’t activate when they don’t need to. When complement factor H isn’t working properly (when the CFH gene is mutated), it doesn’t protect your cells as it should. When that happens:
A provider usually diagnoses aHUS based on your symptoms and the results of tests that check your blood counts and how well your organs are working. They may also perform tests that rule out other conditions that cause similar symptoms (like STEC-HUS).
You might need the following tests and procedures:
How a healthcare provider treats aHUS depends on the underlying cause and severity. If you have a milder form of aHUS, your provider may monitor you and provide supportive care, like blood transfusions or high blood pressure medications.
If you have severe aHUS, you might need:
Advertisement
For people who have complement mutations, providers commonly use medications such as eculizumab to treat atypical hemolytic uremic syndrome. Eculizumab blocks certain complement proteins, preventing your immune system from damaging your blood vessels.
Eculizumab can reduce the amount of protection you receive from meningococcal and pneumococcal vaccinations. If possible, your provider may encourage you to get these vaccinations before starting eculizumab.
Since it’s most often caused by genetic changes, you usually can’t prevent aHUS. If you’re at risk for severe illness, you may be able to avoid certain triggers.
If identified and caught early, providers can successfully treat episodes of acute kidney injury caused by aHUS. You can experience periods of remission (times where you don’t have symptoms) but you could have another life-threatening episode if something triggers aHUS again.
Previously, up to 50% of people with aHUS progressed to end-stage kidney disease (ESKD, the last stage of kidney failure). But studies suggest eculizumab treatment has significantly reduced the risk of ESRD in people with aHUS.
Acute episodes of aHUS — involving kidney failure or other organ damage — are serious. There’s about a 15% risk of dying during an acute episode.
Advertisement
If you’ve been diagnosed with aHUS, talk to your provider about ways to avoid things that could trigger an episode. Make sure you know what signs and symptoms of severe illness to look out for.
Talk to your healthcare provider if you’ve been feeling run-down or fatigued for a long time — like you’ve gotten something you just can’t shake. Tell them about any other symptoms you’ve been experiencing lately, like changes you’ve noticed in your bathroom habits.
Go to the emergency room if you’re experiencing severe symptoms, including:
It may be helpful to ask your healthcare provider:
AHUS is rare. It affects about 1 in 500,000 people. It’s slightly more common in adults than in children.
A note from Cleveland Clinic
Finding out you or your child has a genetic condition can be life-changing. AHUS can be serious, causing blood clots that lead to organ damage. But recently, the use of eculizumab has greatly improved the outlook for people with aHUS. If you’ve been diagnosed with aHUS, ask your provider about ways to avoid potential triggers and reduce your risk of severe illness. They can help you understand what tools you need to stay healthy.
Advertisement
Last reviewed on 11/29/2023.
Learn more about the Health Library and our editorial process.